trending Market Intelligence /marketintelligence/en/news-insights/trending/KONsb7298mOz2pt3l58THw2 content esgSubNav
In This List

Versartis chief development officer to leave

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection


Versartis chief development officer to leave

Versartis Inc. said Chief Development Officer Colin Hislop's employment will be terminated, effective Oct. 20.

Hislop joined Versartis in 2016 from Anthera Pharmaceuticals Inc., where he served as the company's chief medical officer.